The American Diabetes Association’s (ADA) 80th Scientific Sessions is almost here! From June 12-16, scientists and healthcare professionals will gather, virtually, at one of the largest conferences of diabetes researchers in the world. Breakthrough T1D researchers and Breakthrough T1D-funded scientists will also be there virtually to hear first-hand and present new study results that will improve outcomes for people with diabetes (T1D). Read what’s happening below.
ADA’s 80th Scientific Sessions
- The Scientific Sessions is one of the largest gatherings of diabetes researchers in the world, where scientists and healthcare professionals share and learn about new diabetes advances with top experts.
- JDRF-supported research has been highlighted at this annual event since Breakthrough T1D started funding research, showcasing new breakthroughs and therapies for people with T1D. This year, researchers will present 100+ studies—with Breakthrough T1D-funding at present or in the past—encompassing breakthrough clinical trials and significant research studies that are paving the way to novel and emerging treatments for T1D.
- JDRF-funded researchers will outline new advances like:
Curing T1D
-
- Beta Cell Therapies
- What is happening to islet stress in the development of T1D?
- Where shall we get the islet cells from: stem cells, generation of new beta cells or other cell types?
- Immune Therapies
- What combination immune therapies demonstrate initial success?
- Can we manipulate the gut microbiome to treat T1D?
- Beta Cell Therapies
Improving Lives
-
- Glucose Control
- HbA1c vs. time-in-range in pediatric settings—are we there yet?
- What are the clinical trial results of the next generation artificial pancreas systems?
- Complications
- Are we ready for precision medicine trials in diabetic kidney disease?
- What are the strategies for people in underrepresented and underserved communities?
- Glucose Control
- Throughout the Scientific Sessions, Breakthrough T1D will be sharing updates to keep people apprised of the day-to-day happenings:
- Blog posts before, during and after the ADA meeting
- A Facebook Live event (@myJDRF) for each day, from 7:30-8pm ET, with Breakthrough T1D-funded scientists talking about the takeaways from that day
- A “happy hour” with President and CEO Aaron J. Kowalski, Ph.D., from 8-9pm ET on Monday, June 15, speaking about the takeaways from the first four days and a Q&A period to answer questions from you, via Facebook Live (@myJDRF)
- Interviews with Breakthrough T1D-funded scientists, who will go over their research and what it means to the T1D community, to be pushed out on social media
- To stay updated, follow us on Facebook (@myJDRF) and Twitter (@JDRF and @JDRFResearch), with the hashtags #JDRFxADA and #ADA2020
To read about the conference, go to the ADA Scientific Sessions here.